These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17016907)

  • 1. [Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe].
    Smorodinova IuV; Shcherbaniuk AI; Ryzhko IV; Moldavan IA
    Antibiot Khimioter; 2005; 50(8-9):23-6. PubMed ID: 17016907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague].
    Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV
    Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ofloxacin efficacy in the prophylaxis and treatment of experimental plague due to antigen complete and defective strains of the pathogen].
    Samokhodkina ED; Shcherbaniuk AI; Ryzhko IV; Tsuraeva RI; Skalyga EIu
    Antibiot Khimioter; 2002; 47(3):26-9. PubMed ID: 16127904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of cefixime and cefepime vs. other cephalosporins in experimental plague of albino mice due to variants FI+ and FI- of the plague microbe].
    Ryzhko IV; Shcherbaniuk AI; Moldavan IA; Tsuraeva RI; Anisimov BI; Trishina AV
    Antibiot Khimioter; 2007; 52(9-10):24-7. PubMed ID: 20583467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of outcomes of combined specific prophylaxis with the antibiotic resistant immunogenic plague pathogen strain and emergency prophylaxis with aminoglycosides in the experimental plague model in white mice].
    Ryzhko IV; Tsuraeva RI; Moldavan IA; Shcherbaniuk AI; Shut'ko AG
    Antibiot Khimioter; 2003; 48(5):15-9. PubMed ID: 12968464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe].
    Shcherbaniuk AI; Liukshina EIu; Ryzhko IV; Smorodinova IuV
    Antibiot Khimioter; 2006; 51(1):7-10. PubMed ID: 16734358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Doxycycline in the prevention of experimental plague induced by plague microbe variants].
    Samokhodkina ED; Ryzhko IV; Shcherbaniuk AI; Kasatkina IV; Tsuraeva RI; Zhigalova TA
    Antibiot Khimioter; 1992 Nov; 37(11):26-8. PubMed ID: 1300930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice].
    Ryzhko IV; Tsuraeva RI; Anisimov BI; Trishina AV
    Antibiot Khimioter; 2009; 54(5-6):37-40. PubMed ID: 20052916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of etiotropic therapy of plaque infection induced by atypical strains of F1- phenotype plaque microbe].
    Ryzhko IV; Samokhodkina ED; Tsuraeva RI; Shcherbaniuk AI; Tsetskhladze NS
    Antibiot Khimioter; 1998; 43(9):24-8. PubMed ID: 9791683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefoperazone in the prevention and treatment of experimental plague caused by typical and fraction-free pathogen strains in white mice].
    Pasiukov VV; Ryzhko IV; Tsuraeva RI; Samokhodkina ED; Roshchina NV
    Antibiot Khimioter; 1994 Aug; 39(8):37-40. PubMed ID: 7695439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))].
    Ryzhko IV; Trishina AV; Verkina LM
    Antibiot Khimioter; 2010; 55(11-12):22-4. PubMed ID: 21574421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ceftriaxone in prevention and treatment of experimental plague infection].
    Ryzhko IV; Samokhodkina ED; Zhigalova TA
    Antibiot Khimioter; 1993 Jan; 38(1):39-42. PubMed ID: 8060183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen].
    Samokhodkina ED; Ryzhko IV; Tsuraeva RI; Pasiukov VV
    Antibiot Khimioter; 1994 Jul; 39(7):20-3. PubMed ID: 7840704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of monoclonal antibodies to plague microbe antigens at the early stage of infection in white mice for enhancement of the late streptomycin and doxycycline treatment].
    Ryzhko IV; Tsuraeva RI; Alekseeva LP; Shcherbaniuk AI; Mishan'kin MB
    Antibiot Khimioter; 2003; 48(3):21-5. PubMed ID: 12914117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromosomal resistance of plague agent to quinolones].
    Kasatkina IV; Shcherbaniuk AI; Makarovskaia LN; Padeĭskaia EN
    Antibiot Khimioter; 1991 Aug; 36(8):35-7. PubMed ID: 1661573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of plague prophylaxis with streptomycin, tetracycline, and rifampicin in simultaneous immunization of white mice by resistant EV NRIEG strain].
    Ryzhko IV; Tsuraeva RI; Moldavan IA; Shcherbaniuk AI
    Antibiot Khimioter; 2004; 49(1):17-21. PubMed ID: 15164519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of rifampicin in experimental plague infection].
    Makarovskaia LN; Shcherbaniuk AI; Bugaeva OK
    Antibiot Khimioter; 1993 Jul; 38(7):34-6. PubMed ID: 8161275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the effect of antibiotics on the vital activity of plague microbe absorbed by macrophages].
    Zurabian VA; Markovskaia EI; Popova GO; Mikhalevich RV; Makarovskaia LN
    Antibiot Khimioter; 1994 Apr; 39(4):29-31. PubMed ID: 7826170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
    Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1].
    Ryzhko IV; Shcherbaniuk AI; Tsuraeva RI; Samokhodkina ED; Kasatkina IV; Tsetskhladze NS; Pasiukov VV; Roshchina NV
    Antibiot Khimioter; 1997; 42(1):12-6. PubMed ID: 9221699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.